Wheadon David E. bought INDV
January 5, 2026 · Form 4 insider transaction
Wheadon David E. bought 1,771 shares of Indivior Pharmaceuticals, Inc. at $35.39 per share, a transaction worth $62.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,771
Price
$35.39
Total value
$62.7K
InsiderWheadon David E.
Role—
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after14,395
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash.